Zions Bank
1 S Main St, Salt Lake City, UT, 84111, United States
Overview
Zions First National Bank was founded in Salt Lake City in 1873 and continues its legacy of strength and stability as one of the oldest financial institutions in the Intermountain West. To bring value to individuals, small-to middle-market businesses, nonprofits, corporations and institutions, Zions Bank provides a wide range of traditional banking and innovative technology services. Through its network of 125 full-service financial centers across Utah, Idaho and Wyoming, the bank offers consumers a range of mortgage and home equity loan options, AmaZing Rewards:registered: credit cards, Private and Executive Banking services, and online and mobile banking. Dedicated to supporting economic development in the communities it serves, Zions Bank is a consistent market leader in US Small Business Administration lending and is known for its local decision making. Companies can find solutions through the bank’s range of commercial loans, international banking services and award-winning Treasury Management solutions.
- Total investments
- 4
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 8
Sector focus
- Banking
- Finance
- Financial Services
- FinTech
Investment portfolio
- Torus
Participated · Equity · Apr 2024
Torus designs, develops and manufactures mesh-based distributed energy infrastructure that integrates battery and inertial storage systems, AI-based management, cybersecurity, and long-term operations and maintenance. Its platform targets utilities, data centers, manufacturers and commercial and industrial facilities to improve resilience and reduce costs. The company is based in South Lake City, UT. Torus plans to expand manufacturing capacity and scale production at its new GigaOne manufacturing and assembly facility using the recently secured debt financing. The announcement did not disclose revenue, user metrics, or prior funding round details.
- Brim Financial
Participated · Series C · Apr 2024
Brim Financial is a Canadian fintech providing a fully integrated Payments and Cards Platform-as-a-Service that combines mobile and web experiences with extensive API functionality. The solution allows financial institutions and enterprises to configure, launch and manage credit-card and embedded-banking products within a single technology stack, eliminating the need for multiple vendors. Brim’s architecture offers omni-channel servicing, rapid deployment and granular control across the entire card value chain. The company positions itself as a Funding-as-a-Service partner, bundling technology with access to capital so clients can scale new card programs faster. Industry recognition includes placements on Deloitte’s Fast 50/500 lists, CB Insights’ Top 100, Datos Insights’ Best Business Platforms, and PayTech & Banking Tech Award wins in 2025. Brim is regarded as one of the fastest-growing fintechs globally. The newly secured credit facility strengthens its balance sheet and provides additional resources to support client growth.
- Proskriptive
Participated · Equity · Jan 2015
Proskriptive is a Boise, Idaho–based software company launched in April 2014 by CEO Michael Hollenbeck. It provides a SaaS Wellness Automation predictive platform that applies machine learning to healthcare data to prescribe high-impact, low-cost interventions for patients before hospitalization or readmission. The platform is designed to promote outpatient wellcare by identifying patients in need of care earlier. In January 2015 the company raised $400K in a mix of equity and debt financing. Backers included Brian Seaberg and Zion's Bank. Proskriptive said it will use the funds to accelerate development of its Wellness Automation Platform.
- Amedica Corporation
Led · Debt Financing · Sep 2010
Amedica Corporation is an emerging orthopaedic implant company based in Salt Lake City, Utah, that develops and commercializes spine and total joint implants using silicon nitride ceramic and other technologies. The company has brought various spinal implant products to market and is developing reconstructive hip and knee implants. Amedica's products are FDA cleared, CE approved and the company is ISO 13485 certified. It has completed transactions in excess of $100M in the recent past. Amedica completed a $30M financing—$15M in private equity and a $15M debt facility—and plans to use the proceeds for expansion, mergers and acquisitions, and sales and marketing support. Management stated the financing will enable and further sustain the company's substantial growth.